… The communication between the microbiota and SARS-CoV-2 and … SARS-CoV-2 infection
may help predict patient outcomes and allow the development of microbiota-based therapies…

… In this article, we consider the role of antifibrotic therapy with pirfenidone in patients with
SARS-CoV-2 infection on going or in the stage of postinfection with pulmonary fibrotic …

… ACE2 as an important therapeutic target of SARS-CoV-2 entry … summarize the potential
therapeutic targets involved in the … ) indicated the potential therapeutic value of RNA aptamers …

… Pseudovirus neutralization assays revealed that H014 has potent neutralizing activities:
a 50% neutralizing concentration value (IC 50 ) of 3 nM and 1 nM against SARS-CoV-2 and …

… They are eco-friendly molecules which can have therapeutic value. Several phytochemicals
such as alkaloids, terpenoids, saponins,and polyphenols are reported to possess antiviral …

… of SARS-CoV-2 infection, and additional potent anti-SARS-CoV-… clinical challenges of
anti-SARS-CoV-2 agents to provide … needed to assess the therapeutic value of FVP in COVID-19. …

… In this article, we summarize all the therapeutic antiviral … , vaccines, plasma therapy, various
adjunct therapies, and phage … to block SARS-CoV-2 virus infection, with an IC 50 value of …

… parameter values (Table 1), we conducted in silico experiments for possible anti-SARS-CoV-2
therapies to investigate the expected outcome under hypothetical drug therapies (or …

… [Citation22] assessed the in vitro cytotoxic properties of NTZ against SARS-CoV-2 with an
EC 50 value of 2.12 µM, determined by CCK-8 assays on Vero E6 cells. The EC 50 values for …

… -2 RBD, SBP-1 was found to potently bind to the SARS-CoV-2 RBD with a K D value of 47
nM, … These proteases have been confirmed as valuable therapeutic targets, and the inhibitors …